These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21995392)

  • 1. The problems with surveillance of Barrett's esophagus.
    Kahrilas PJ
    N Engl J Med; 2011 Oct; 365(15):1437-8. PubMed ID: 21995392
    [No Abstract]   [Full Text] [Related]  

  • 2. Adenocarcinoma in Barrett's esophagus.
    Barret M; Chaussade S; Coriat R
    N Engl J Med; 2011 Dec; 365(26):2539; author reply 2539-40. PubMed ID: 22204731
    [No Abstract]   [Full Text] [Related]  

  • 3. Barrett's esophagus: does the incidence of adenocarcinoma matter?
    Cameron AJ
    Am J Gastroenterol; 1997 Feb; 92(2):193-4. PubMed ID: 9040189
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence of adenocarcinoma among patients with Barrett's esophagus.
    Hvid-Jensen F; Pedersen L; Drewes AM; Sørensen HT; Funch-Jensen P
    N Engl J Med; 2011 Oct; 365(15):1375-83. PubMed ID: 21995385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years.
    Drewitz DJ; Sampliner RE; Garewal HS
    Am J Gastroenterol; 1997 Feb; 92(2):212-5. PubMed ID: 9040193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yield of Higher-Grade Neoplasia in Barrett's Esophagus With Low-Grade Dysplasia Is Double in the First Year Following Diagnosis.
    Rubenstein JH; Waljee AK; Dwamena B; Bergman J; Vieth M; Wani S
    Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1529-1530. PubMed ID: 29307847
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictors of Progression to High-Grade Dysplasia or Adenocarcinoma in Barrett's Esophagus.
    Whitson MJ; Falk GW
    Gastroenterol Clin North Am; 2015 Jun; 44(2):299-315. PubMed ID: 26021196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding cancer incidence in Barrett's esophagus: light at the end of the tunnel.
    Corley DA
    J Natl Cancer Inst; 2011 Jul; 103(13):994-5. PubMed ID: 21680911
    [No Abstract]   [Full Text] [Related]  

  • 9. Barrett's esophagus and cancer risk: a more realistic estimate.
    Rajendra S; Sharma P
    Semin Thorac Cardiovasc Surg; 2011; 23(4):261-2. PubMed ID: 22443641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.
    Provenzale D; Schmitt C; Wong JB
    Am J Gastroenterol; 1999 Aug; 94(8):2043-53. PubMed ID: 10445526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry.
    O'Connor JB; Falk GW; Richter JE
    Am J Gastroenterol; 1999 Aug; 94(8):2037-42. PubMed ID: 10445525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.
    Rugge M; Fassan M; Cavallin F; Zaninotto G
    J Natl Cancer Inst; 2012 Nov; 104(22):1771-2. PubMed ID: 23042934
    [No Abstract]   [Full Text] [Related]  

  • 13. Barrett's esophagus.
    Phillips WA; Lord RV; Nancarrow DJ; Watson DI; Whiteman DC
    J Gastroenterol Hepatol; 2011 Apr; 26(4):639-48. PubMed ID: 21166712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in outlining the frequency and risk of recurrent neoplasia after ablation of Barrett's esophagus.
    Peters JH
    Gastrointest Endosc; 2010 Apr; 71(4):704-5. PubMed ID: 20363412
    [No Abstract]   [Full Text] [Related]  

  • 15. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
    Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
    Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barrett's esophagus.
    Byrd D; McKinley MJ; Floch MH; Nair S
    Gastroenterologist; 1994 Jun; 2(2):160-5. PubMed ID: 8055240
    [No Abstract]   [Full Text] [Related]  

  • 17. Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus.
    Kastelein F; Spaander MC; Biermann K; Steyerberg EW; Kuipers EJ; Bruno MJ;
    Gastroenterology; 2011 Dec; 141(6):2000-8; quiz e13-4. PubMed ID: 21878200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etiology of Barrett's metaplasia and esophageal adenocarcinoma.
    Kim R; Weissfeld JL; Reynolds JC; Kuller LH
    Cancer Epidemiol Biomarkers Prev; 1997 May; 6(5):369-77. PubMed ID: 9149898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Barrett esophagus: epidemiologic data and risk of becoming malignant].
    García Marcilla JA; Parrilla Paricio P; Ortiz Escandell MA; Martínez de Haro LF; Aguado Albasini JL; Molina Martínez J; Rodríguez Bermejo M
    Rev Esp Enferm Apar Dig; 1989 Nov; 76(5):419-23. PubMed ID: 2694239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenocarcinoma of the lower esophagus. A disease primarily of white men with Barrett's esophagus.
    Rogers EL; Goldkind SF; Iseri OA; Bustin M; Goldkind L; Hamilton SR; Smith RL
    J Clin Gastroenterol; 1986 Dec; 8(6):613-8. PubMed ID: 3805655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.